Questions About Cancer? 1-800-4-CANCER

Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)

Health Professional Version
Last Modified: 02/03/2012

Changes to This Summary (02/03/2012)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Osteosarcoma and Malignant Fibrous Histiocytoma (MFH) of Bone 1

The Genetic diseases that predispose to osteosarcoma 2 subsection was renamed from Inherited diseases that predispose to osteosarcoma.

Recurrent Osteosarcoma and MFH of Bone 3

Added text 4 to state that in 564 patients with a recurrence, patients whose disease recurred within 2 years of diagnosis had a worse prognosis than did patients whose disease recurred after 2 years; patients with a good histologic response to initial preoperative chemotherapy had a better overall survival after recurrence than did poor responders (cited Gelderblom et al. as reference 1).

Table of Links

1http://www.cancer.gov/cancertopics/pdq/treatment/osteosarcoma/HealthProfessiona
l/#Section_1
2http://www.cancer.gov/cancertopics/pdq/treatment/osteosarcoma/HealthProfessiona
l/#Section_381
3http://www.cancer.gov/cancertopics/pdq/treatment/osteosarcoma/HealthProfessiona
l/Page7#Section_44
4http://www.cancer.gov/cancertopics/pdq/treatment/osteosarcoma/HealthProfessiona
l/Page7#Section_45